Hao Bai

Dr. Hao Bai

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Acta Astronautica
Verified
Journal Article
Closed access
XFXiu Feng
Xiu Feng
HZHeng Zhou
Heng Zhou
YZYanan Zhang
Yanan Zhang
PYPengfei Yang
Pengfei Yang
HBHao Bai
Hao Bai
JWJufang Wang
Jufang Wang

Verified
Journal Article
Open access
PDF file
WWWenjun Wei
Wenjun Wei
HBHao Bai
Hao Bai
YCYaxiong Chen
Yaxiong Chen
TZTongshan Zhang
Tongshan Zhang
YZYanan Zhang
Yanan Zhang
JWJufang Wang
Jufang Wang
The effective and minimally invasive radiation biomarkers are valuable for exposure scenarios in nuclear accidents or space missions. Recent studies have opened the new sight of circulating small non-coding RNA (sncRNA) as radiation biomarkers. The tRNA-derived small RNA (tsRNA) is a new class of sncRNA. It is more abundant than other kinds of sncRNAs in extracellular vesicles or blood, presenting great potential as promising biomarkers. However, the circulating tsRNAs in response to ionizing radiation have not been reported. In this research, Kunming mice were total-body exposed to 0.05–2 Gy of carbon ions, protons, or X-rays, and the RNA sequencing was performed to profile the expression of sncRNAs in serum. After conditional screening and validation, we firstly identified 5 tsRNAs including 4 tRNA-related fragments (tRFs) and 1 tRNA half (tiRNA) which showed a significant level decrease after exposure to three kinds of radiations. Moreover, the radiation responses of these 5 serum tsRNAs were reproduced in other mouse strains, and the sequences of them could be detected in serum of humans. Furthermore, we developed multi-factor models based on tsRNA biomarkers to indicate the degree of radiation exposure with high sensitivity and specificity. These findings suggest that the circulating tsRNAs can serve as new minimally invasive biomarkers and can make a triage or dose assessment from blood sample collection within 4 h in exposure scenarios.

1 January 2020 in Dose-Response
Verified
Journal Article
Open access
PDF file
WWWenjun Wei
Wenjun Wei
HBHao Bai
Hao Bai
XFXiu Feng
Xiu Feng
JHJunrui Hua
Junrui Hua
KLKaiqin Long
Kaiqin Long
HZHeng Zhou
Heng Zhou
Exposure to ionizing radiation is a major threat to human health and public security. Since the inherent limitations of current methods for indicating radiation exposure, new minimally invasive biomarkers that can be easily and quickly detected at an early stage are needed for optimal medical treatment. Serum proteins are attractive biomarkers and some radiosensitive proteins have been found, but the proteins in response to low-dose and high-linear energy transfer (LET) radiation have not been reported. In this study, mice were whole body exposed to a variety doses of carbon ions and X-rays. We performed Mouse Antibody Array to detect serum proteins expression profiles at 24 hours postirradiation. After conditional screening, insulin-like growth factor-1 (IGF-1), insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 were further validated using enzyme-linked immunosorbent assay. After exposure to 0.05 to 1 Gy of carbon ions and 0.5 to 4 Gy of X-rays, only IGFBP-3 showed obvious increase with increased doses, both carbon ions and X-rays. Further, IGFBP-3 was detected for observation of its time-dependent changes. The results showed the expression difference of IGFBP-3 presented from 6 to 24 hours post-irradiation by carbon ions and X-rays. Moreover, the receiver–operating characteristic analysis showed that serum IGFBP-3 is efficient to triage exposed individuals with high sensitivity and specificity. These results suggest that serum IGFBP-3 is extremely sensitive to high- and low-LET ionizing radiation and is able to respond at an early stage, which could serve as a novel minimally invasive indicator for radiation exposure.

1 September 2021 in Acta Astronautica
Verified
Journal Article
Closed access
HBHao Bai
Hao Bai
TZTongshan Zhang
Tongshan Zhang
JWJufang Wang
Jufang Wang
JHJunrui Hua
Junrui Hua
WWWenjun Wei
Wenjun Wei

17 September 2025 in Acta Pharmaceutica Sinica B
Verified
Journal Article
Open access
JSJiawei Song
Jiawei Song
LYLu Ye
Lu Ye
Wei-Qun DingWei-Qun Ding
Wei-Qun Ding
HQHuaijin Qiao
Huaijin Qiao
JDJunlong Dai
Junlong Dai
SZShuyu Zhang
Shuyu Zhang
Cancer remains the leading cause of mortality worldwide. Radiotherapy (RT), a cornerstone of oncological treatment for over a century, has achieved great success in various cancers. However, radioresistance remains the primary factor leading to the failure of radiotherapy. Histone modifications in cancer cells are known to play a pivotal role in regulating radiosensitivity by modulating chromatin structure, either by loosening or tightening it. Here, we provide a comprehensive summary of the link between aberrant histone modifications and radiation resistance across various cancer and normal tissue cells. Furthermore, we discuss the regulatory mechanisms of histone modifications and the enzymes on the recruitment of proteins that recognize histone modifications. Consequently, these processes substantially affect the radiosensitivity of tumors. In addition to cancer cells, we highlight the intricate interplay between histone modification and radiosensitivity, both within and beyond the cancer cells. Meanwhile, various drugs targeting histone modifications emerge as a promising therapeutic strategy to overcome radioresistance of tumors as well as radioprotection. The combination of histone modification inhibitors with radiotherapy presents a novel approach to enhance cancer treatment outcomes in clinical practice. Nevertheless, the underlying mechanisms through which histone modifications influence cancer radiosensitivity require further elucidation to identify novel targets for radiotherapeutic intervention.